Home/Pipeline/Sovateltide

Sovateltide

Hypoxic‑Ischemic Encephalopathy (Neonates)

Phase 2Active

Key Facts

Indication

Hypoxic‑Ischemic Encephalopathy (Neonates)

Phase

Phase 2

Status

Active

Company

Pharmazz, Pharmazz

About Pharmazz

Innovative biotech delivering endothelin‑based drugs for critical care and neuroscience.

View full company profile

About Pharmazz

Innovative biotech delivering endothelin‑based drugs for critical care and neuroscience.

View full company profile

Therapeutic Areas

Neuroscience Cardiovascular Critical Care